trans Activation of an Epstein-Barr Viral Transcriptional Enhancer by the Epstein-Barr Viral Nuclear Antigen 1

LITERATURE CITED

• Arrand, J. R., and L. Rymo. 1982. Characteristics of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells. J. Virol. 41:376–389.
   PubMed Web of Science ®Google Scholar
• Baer, R., A. T. Bankier, M. D. Biggin, P. L. Dieninger, P. J. Farrell, T. J. Gibson, G. Hatfull, G. S. Hudson, S. C. Satchwell, C. Sequin, P. S. Tuffnell, and B. G. Barrell. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature (London) 310:207–211.
   PubMed Web of Science ®Google Scholar
• Berk, A. J., F. Lee, T. Harrison, J. Williams, and P. Sharp. 1979. Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs. Cell 17:935–944.
   PubMed Web of Science ®Google Scholar
• Bodescot, M., B. Chambraud, P. Farrell, and M. Perricaudet. 1984. Spliced RNA from the 1R1-U2 region of Epstein-Barr virus: presence of an open reading frame for a repetitive polypeptide. EMBO J. 3:1913–1917.
   PubMedGoogle Scholar
• Broome, S., and W. Gilbert. 1985. Rous sarcoma virus encodes a transcriptional activator. Cell 40:537–546.
   PubMedGoogle Scholar
• Cheah, M. S. C., T. J. Ley, S. R. Tronick, and K. C. Robbins. 1986. fgr proto oncogene mRNA induced in B-lymphocytes by Epstein-Barr virus infection. Nature (London) 319:238–240.
   PubMed Web of Science ®Google Scholar
• Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299.
   PubMed Web of Science ®Google Scholar
• Denhardt, D. T. 1966. A membrane filter technique for the detection of complementary DNA. Biochem. Biophys. Res. Commun. 23:641–646.
   PubMed Web of Science ®Google Scholar
• de Villiers, J., W. Schaffner, C. Tyndall, S. Lupton, and R. Kamen. 1984. Polyoma virus DNA replication requires an enhancer. Nature (London) 312:242–246.
   PubMed Web of Science ®Google Scholar
• Dixon, R. A. F., and P. A. Schaffer. 1980. Fine-structure mapping and functional analysis of temperature-sensitive mutants in the gene encoding the herpes simplex virus type 1 immediate early protein VP 175. J. Virol. 36:189–203.
   PubMed Web of Science ®Google Scholar
• Fennewald, S., V. van Santen, and E. Kieff. 1984. Nucleotide sequence of an mRNA transcribed in latent growth transforming virus infection indicates that it may encode a membrane protein. J. Virol. 51:411–419.
   PubMed Web of Science ®Google Scholar
• Fromm, M., and P. Berg. 1982. Deletion mapping of DNA regions required for SV40 early promoter function in vivo. J. Mol. Appl. Genet. 1:457–481.
   PubMedGoogle Scholar
• Glaser, R., and M. Nonoyama. 1973. Host cell replication and induction of Epstein-Barr virus. J. Virol. 14:174–176.
   Google Scholar
• Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044–1051.
   PubMed Web of Science ®Google Scholar
• Graham, F. L., S. Bacchetti, R. McKinnon, B. Cordell, and H. Goodman. 1979. Transformation of mammalian cells with DNA using the calcium technique. In R. Basergan (ed.), Introduction of macromolecules into viable mammalian cells. Wistar Symposium Series, vol. 1. Alan R. Liss, Inc., New York.
   Google Scholar
• Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 5:456–467.
   Google Scholar
• Hennessey, K., M. Heller, V. van Santen, and E. Kieff. 1983. Simple repeat array in Epstein-Barr virus DNA encodes part of the Epstein-Barr nuclear antigen. Science 220:1396–1399.
   PubMedGoogle Scholar
• Hennessey, K., and E. Kieff. 1985. A second nuclear protein is encoded by Epstein-Barr virus in latent infection. Science 227:1238–1240.
   PubMedGoogle Scholar
• Hertz, G., and J. Mertz. 1986. Bidirectional promoter elements of simian virus 40 are required for efficient replication of viral DNA. Mol. Cell. Biol. 6:3513–3522.
   PubMed Web of Science ®Google Scholar
• Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365–369.
   PubMed Web of Science ®Google Scholar
• Hudson, G. S., A. T. Bankier, S. C. Satchwell, and B. Baverell. 1985. The short unique region of the B95-8 Epstein-Barr virus genome. Virology 147:1–98.
   PubMedGoogle Scholar
• Jones, N., and T. Shenk. 1979. An adenovirus 5 early gene product function regulates expression of other early viral genes. Proc. Natl. Acad. Sci. USA 76:3665–3669.
   PubMed Web of Science ®Google Scholar
• Kavathas, P., F. H. Bach, and R. DeMars. 1980. Gamma ray-induced loss of expression of HLA and glyoxalase alleles in lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 77:4251–4255.
   PubMedGoogle Scholar
• Keller, J. M., and S. C. Alwine. 1984. Activation of the SV40 late promoter: direct effects of T antigen in the absence of viral DNA replication. Cell 36:381–389.
   PubMed Web of Science ®Google Scholar
• Klein, G., B. Giovanella, A. Westman, J. S. Stehlin, and D. Mumford. 1975. An EBV-genome negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology 5:319–334.
   PubMed Web of Science ®Google Scholar
• Klein, G., T. Lindahl, M. Jondal, W. Leibold, J. Meneles, K. Nilsson, and C. Sundstrom. 1974. Continuous lymphoid cell lines with characteristics of B-cells (bone marrow derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc. Natl. Acad. Sci. USA 71:3283–3286.
   PubMed Web of Science ®Google Scholar
• Laimins, A. L., G. Khoury, C. Gorman, B. Howard, and P. Gruss. 1982. Host-specific activation of transcription by tandem repeats from simian virus 40 and Moloney murine sarcoma virus. Proc. Natl. Acad. Sci. USA 79:6453–6457.
   PubMed Web of Science ®Google Scholar
• Lindahl, T., A. Adams, G. Bjursell, G. W. Bomkamm, C. Kaschka-Dierich, and U. Jehn. 1976. Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line. J. Mol. Biol. 102:511–530.
   PubMed Web of Science ®Google Scholar
• Lowry, D. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265–275.
   PubMed Web of Science ®Google Scholar
• Lupton, S., and A. J. Levine. 1985. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells. Mol. Cell. Biol. 5:2533–2542.
   PubMed Web of Science ®Google Scholar
• Myers, R. M., D. C. Rio, A. K. Robbins, and R. Tjian. 1981. SV40 gene expression is modulated by the cooperative binding of T antigen to DNA. Cell 25:373–384.
   PubMed Web of Science ®Google Scholar
• Miller, G. 1985. Epstein-Barr virus, p. 563–590. In B. Fields (ed.), Virology. Raven Press, New York.
   Google Scholar
• Preston, C. M. 1979. Control of herpes simplex virus type 1 mRNA synthesis in cells infected with wild-type virus or the temperature-sensitive mutant tsk. J. Virol. 29:275–284.
   PubMedGoogle Scholar
• Pulvertaft, R. J. V. 1965. A study of malignant tumors in Nigeria by short-term tissue culture. J. Clin. Pathol. 18:261–271.
   PubMed Web of Science ®Google Scholar
• Rawlins, D. R., G. Milman, S. D. Hayward, and G. S. Hayward. 1985. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell 42:859–868.
   PubMed Web of Science ®Google Scholar
• Reedman, B. M., and G. Klein. 1973. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int. J. Cancer 11:499–520.
   PubMed Web of Science ®Google Scholar
• Reisman, D., J. Yates, and B. Sugden. 1985. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol. Cell. Biol. 5:1822–1832.
   PubMed Web of Science ®Google Scholar
• Sodroski, J. G., W. C. Goh, C. A. Rosen, S. Z. Salahuddin, A. Aldouini, G. Franchini, F. Wong-Staal, R. C. Gallo, K. Sugamura, Y. Hinuma, and W. A. Haseltine. 1985. Trans- activation of the human T-cell leukemia virus long terminal repeat correlates with expression of the x-los protein. J. Virol. 55:831–835.
   PubMed Web of Science ®Google Scholar
• Spalholz, B. A., Y. C. Yang, and P. M. Howley. 1985. Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene product. Cell 42:183–191.
   PubMed Web of Science ®Google Scholar
• Speck, S. H., and J. L. Strominger. 1985. Analysis of the transcript encoding the latent Epstein-Barr virus nuclear antigen. I. A potentially polycistronic message generated by long- range splicing of several exons. Proc. Natl. Acad. Sci. USA 82:8205–8309.
   Google Scholar
• Stinski, M. F., and T. J. Roehr. 1985. Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulating sequence and by virusspecific trans-acting components. J. Virol. 55:431–441.
   PubMed Web of Science ®Google Scholar
• Sugden, B., K. Marsh, and J. Yates. 1985. A vector that replicates as a plasmid can be efficiently selected in B- lymphoblasts transformed by EBV. Mol. Cell. Biol. 5:410–413.
   PubMedGoogle Scholar
• Sugden, B., M. Phelps, and J. Domoradski. 1979. Epstein-Barr virus DNA is amplified in transformed lymphocytes. J. Virol. 31:590–595.
   PubMed Web of Science ®Google Scholar
• Summers, W. P., E. A. Grogan, D. Shedd, M. Robert, C. Liu, and G. Miller. 1982. Stable expression in mouse cells of nuclear neoantigen after transfer of a 3.4-megadalton cloned fragment of Epstein-Barr virus DNA. Proc. Natl. Acad. Sci. USA 79:5688–5692.
   PubMedGoogle Scholar
• Szybalski, W., E. H. Szybalska, and G. Ragni. 1962. Genetic studies with human cell lines. Natl. Cancer Inst. Monogr. 7:75–89.
   Google Scholar
• van Santen, V., A. Cheung, and E. Kieff. 1981. Epstein-Barr virus RNA. VII. Size and direction of transcription of virusspecific cytoplasmic RNAs in a transformed cell line. Proc. Natl. Acad. Sci. USA 78:1930–1935.
   PubMedGoogle Scholar
• White, B., and F. C. Bancroft. 1982. Cytoplasmic dot hybridization. J. Biol. Chem. 257:8569–8572.
   PubMed Web of Science ®Google Scholar
• Yates, J., N. Warren, D. Reisman, and B. Sugden. 1984. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. USA 81:3806–3810.
   PubMed Web of Science ®Google Scholar
• Yates, J. L., N. Warren, and B. Sugden. 1985. Plasmids derived from Epstein-Barr virus replicate stably in a variety of mammalian cells. Nature (London) 313:812–815.
   PubMed Web of Science ®Google Scholar